Table 1 Comparison of baseline characteristics between hypothermic and normothermic surgery group.
Normothermic group (n = 98) | Hypothermic group (n = 95) | |
|---|---|---|
Age (years) † | 66.3 ± 6.2 | 64.7 ± 7.6 |
HTN (n, %) | 41 (42) | 43 (45) |
DM (n, %) | 16 (16) | 17 (18) |
BMI (kg/m2) † | 24.5 ± 3.0 | 24.6 ± 2.7 |
Charlson Comorbidity Index (CCI) (n, %) | ||
CCI 0 | 61 (62.2) | 60 (63.2) |
CCI 1 | 27 (27.6) | 27 (28.4) |
CCI 2–3 | 10 (10.2) | 8 (8.4) |
Pre-operative PSA (ng/dL) † | 7.2 ± 4.7 | 7.5 ± 3.2 |
Prostate volume (mL) † | 38.0 ± 13.1 | 34.7 ± 14.6 |
Period between prostate biopsy and operation (days) † | 61.1 ± 39.5 | 59.7 ± 53.5 |
MRI T stage (n, %) | ||
T0-T2 | 83 (95) | 90 (96) |
T3 | 5 (5) | 4 (4) |
ISUP GG (n, %) | ||
ISUP GG 1–2 | 68 (69) | 75 (79) |
ISUP GG 3–5 | 30 (31) | 20 (21) |
Total IIEF score† | 11.2 ± 7.6 | 11.6 ± 7.4 |
EPIC-CP score† | ||
Urinary incontinence | 1.35 ± 1.48 | 1.14 ± 1.43 |
Urinary subscale | 2.42 ± 2.88 | 2.60 ± 2.84 |
Bowel subscale | 1.18 ± 2.45 | 1.39 ± 2.73 |
Sexual subscale | 4.87 ± 2.28 | 4.73 ± 2.49 |
Hormonal subscale | 0.86 ± 1.90 | 1.29 ± 2.62 |
Total score | 10.7 ± 7.35 | 11.2 ± 8.20 |
EQ-5D-5 L VAS score† | 82.0 ± 12.8 | 80.2 ± 13.3 |
EQ-5D-5 L utility score† | 0.93 ± 0.09 | 0.93 ± 0.09 |
